Setting new standards in information exchange for the pharmaceutical and biotech industry
National Cancer Institute and Merck Research Labs Guests on Pharma Talk Radio Discussing the Exciting Potential and Challenges with Immuno-Oncology
June 5, 2015
Immuno-Oncology is arguably the most exciting area in the advancement of science and patient care today. However, with all research, there are plenty of challenges and to get a better understanding of this innovative approach to cancer research, we were pleased to welcome to Pharma Talk Radio, James Gulley, MD, PhD of the National Cancer Institute and Roy Baynes, MD, PhD at Merck Research Labs. Joining Drs Gulley and Baynes was Kate Woda, Director of the IO360 conference taking place at Columbia University Faculty House on June 29-30 in NYC.
For more details on Immuno-Oncology 360 visit: http://theconferenceforum.org/